Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A bioinformatic study
Nagesha Somakalapalli Narasimhappa, Ramesh B.N., C. Pradeep, et al.
Materials Today Proceedings (2021) Vol. 49, pp. 904-912
Open Access | Times Cited: 20

Showing 20 citing articles:

Antivirals for Broader Coverage against Human Coronaviruses
Mia Outteridge, Christine M. Nunn, Kevin M. Devine, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 156-156
Open Access | Times Cited: 4
SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments
Xirui Zhang, Hao Yuan, Zipeng Yang, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2145-2145
Open Access | Times Cited: 20
Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
Sivaprakasam T. Selvavinayagam, Yean K. Yong, Narcisse Joseph, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 18
Impact of SARS-CoV-2 on the nervous system
Agata Czarnowska, Joanna Zajkowska, Alina Kułakowska
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 26-35
Open Access | Times Cited: 11
Gastrointestinal microbiota: A predictor of COVID-19 severity?
Maria Adriana Neag, Damiana-Maria Vulturar, Diana Gherman, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 45, pp. 6328-6344
Open Access | Times Cited: 15
In Silico Protein Folding Prediction of COVID-19 Mutations and Variants
Sumana Bhowmick, Tim Jing, Wei Wang, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1665-1665
Open Access | Times Cited: 14
A step toward Molnupiravir, COVID-19 Antiviral, detection using Cauliflower-Like cobalt Sulfide-Decorated carbon nanotube modified glassy carbon electrodes
Elham Khezerloo, Farzaneh Hekmat, Saeed Shahrokhian, et al.
Microchemical Journal (2024) Vol. 204, pp. 111072-111072
Closed Access | Times Cited: 2
Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19
Samantha C. Karunarathna, Wenhua Lu, Nimesha Patabedige, et al.
New Zealand Journal of Botany (2024), pp. 1-59
Closed Access | Times Cited: 1
Salmonella-mediated oral delivery of multiple-target vaccine constructs with conserved and variable regions of SARS-CoV-2 protect against the Delta and Omicron variants in hamster
Khristine Kaith S. Lloren, Vijayakumar Jawalagatti, Chamith Hewawaduge, et al.
Microbes and Infection (2023) Vol. 25, Iss. 5, pp. 105101-105101
Open Access | Times Cited: 4
Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform
Fahime Edalat, Fatemeh Hosseini, Afagh Moattari, et al.
Vacunas (2023) Vol. 25, Iss. 1, pp. 109-127
Closed Access | Times Cited: 3
Reaching the Final Endgame for Constant Waves of COVID-19
Norman A. Ratcliffe, Helena Carla Castro, Marcelo Salabert Gonzalez, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2637-2637
Open Access | Times Cited: 5
Performance of the SureScreen Diagnostics COVID-19 antibody rapid test in comparison with three automated immunoassays
Sarah Mafi, Sylvie Ranger‐Rogez, Jérôme Darreye, et al.
Diagnostic Microbiology and Infectious Disease (2023) Vol. 105, Iss. 4, pp. 115900-115900
Open Access | Times Cited: 2
Immunoglobulin Y Specific for SARS-CoV-2 Spike Protein Subunits Effectively Neutralizes SARS-CoV-2 Infectivity and Ameliorates Disease Manifestations In Vivo
Chia‐Tsui Yeh, Chia‐Ying Lee, Yi‐Jung Ho, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2774-2774
Open Access | Times Cited: 4
Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform
Fahime Edalat, Fatemeh Hosseini, Afagh Moattari, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 1, pp. 109-127
Closed Access
Endo-β-N-acetylglucosaminidase EndoE from infant gut Enterococcus faecalis neutralizes SARS-CoV-2 by interacting with the viral spike protein
Eva M. Moya-Gonzálvez, Sergi López-Navarro, Roberto Gozalbo‐Rovira, et al.
Research Square (Research Square) (2024)
Open Access
Antivirals and Biologics for Broader Coverage Against Human Coronaviruses
Mia Outteridge, Christine M. Nunn, Kevin M. Devine, et al.
(2023)
Open Access | Times Cited: 1
Interactions between glucosides of the tip of the S1 subunit of SARS-CoV-2 spike protein and dry and wet surfaces of CuO and Cu—A model for the surfaces of coinage metals
Cláudio M. Lousada
Colloids and Surfaces B Biointerfaces (2022) Vol. 214, pp. 112465-112465
Open Access | Times Cited: 2
Comparative study of effective antibiofilm activity of beneficial microbes-mediated zirconia nanoparticles
Sowmya Balaji, Venkat Kumar Shanmugam
Bioprocess and Biosystems Engineering (2022) Vol. 45, Iss. 11, pp. 1771-1780
Closed Access | Times Cited: 1
Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63
Line Victoria Moen, Hilde Synnøve Vollan, Jon Bråte, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2734-2734
Open Access | Times Cited: 1
SARS-CoV-2 spike trimer complexed with a durable neutralizing antibody 6C6 fab
G. Clabaugh
(2023)
Open Access
Page 1

Scroll to top